Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POLR3KP2 refers to an RNA polymerase III subunit K pseudogene 2. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations, deletions, or truncations that prevent proper transcription or translation. POLR3KP2 is not listed among the 17 functional subunits of human RNA polymerase III, nor is it described in structural, genetic, or disease literature regarding Pol III composition or related disorders[4][5]. As a pseudogene, it is not considered a therapeutic target and is not involved in RNA transcription or any known cellular functions. RNA polymerase III (Pol III) is a multi-subunit enzyme that transcribes small noncoding RNAs (tRNAs, 5S rRNA, U6 snRNA, etc.), with subunits such as POLR3A (RPC1), POLR3B (RPC2), POLR3K (subunit K/RPC10) being part of the active enzyme[2][4][5]. However, pseudogene variants like POLR3KP2 do not encode these functional proteins and are generally excluded from canonical protein lists and structural analyses. No evidence from current scientific literature suggests POLR3KP2 plays any direct biological role or is relevant for disease, therapy, drug targeting, or biomarker development[2][4][5]. If your query seeks functional RNA polymerase III subunits, refer to genes like POLR3A, POLR3B, and POLR3K rather than pseudogenes such as POLR3KP2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase III subunit K pseudogene 2 (POLR3KP2).